Surgimate Partners with ImplantBase to Create Unified Surgical Management Platform
Surgimate, a leading provider of surgical coordination software supported by Banneker Partners, has announced its strategic investment in ImplantBase, a top provider of inventory logistics and sales operations software for medical device companies and their distribution networks.
This partnership marks an important expansion of Surgimate’s capabilities, going beyond surgical coordination to create a unified platform that bridges the gap between surgeons, medical device manufacturers, and distributors. The collaboration will help enhance efficiency and streamline processes throughout the entire surgical journey.
Despite representing a significant portion of U.S. healthcare spending, surgical procedures are often managed using outdated, manual processes and inefficient tools. These inefficiencies can result in errors, delays, and higher costs. Surgimate’s flagship product has already addressed this issue by offering a comprehensive suite of software solutions tailored specifically for surgical practices, improving surgical workflow and reducing operational inefficiencies.
By investing in ImplantBase, Surgimate is expanding its product offering to include inventory management and sales operations for medical device manufacturers and distributors. ImplantBase’s software is designed to help medical device companies and their distributor networks better manage inventory, streamline logistics, and improve sales operations. This integration of surgical coordination and inventory management software will create a seamless workflow from the operating room to the supply chain, enhancing communication between surgeons and the suppliers they depend on. The result is a more efficient and cohesive approach to surgery management that can drive significant improvements in both cost control and patient care.
“The addition of ImplantBase aligns perfectly with our vision of creating a seamless, cost-effective solution that supports every part of the surgical workflow and enhances patient outcomes,” said Kraig Brown, CEO of Surgimate.
“By improving visibility into the surgical pipeline and optimizing operational logistics, we can help practices and health systems reduce costs while ensuring surgeons have the equipment they need, when they need it. We are excited to welcome Ethan and his team to the Surgimate family.”
Ethan Lauer, Founder and CEO of ImplantBase, expressed his enthusiasm for the partnership, emphasizing how the integration of these two technologies will revolutionize the surgical ecosystem. “We are thrilled to join Surgimate and advance our shared vision of connecting the surgical ecosystem and improving patient care,” said Lauer. “The combination of our technologies is a huge step forward, enabling medical device companies to anticipate and respond to surgical demand more effectively than ever before.”
The integration of ImplantBase into Surgimate’s platform will help medical device manufacturers and distributors better manage their inventories by improving visibility into surgical demand. By accurately forecasting the need for medical supplies and equipment, device manufacturers will be able to respond more quickly and efficiently, reducing delays and preventing the overstocking or understocking of critical items. Additionally, the combined platform will provide surgeons with real-time data on available inventory, enabling them to plan surgeries more effectively and avoid unnecessary disruptions during procedures.
The impact of this partnership goes beyond operational efficiency; it has the potential to significantly reduce costs across the entire surgical workflow. By streamlining processes and improving the coordination between medical device manufacturers, distributors, and surgical teams, health systems and surgical practices can lower the cost of surgeries while improving patient outcomes. With better control over inventory, equipment, and supply chain management, hospitals can ensure that they are utilizing their resources more effectively, ultimately improving the overall quality of care.
The transaction officially closed in February 2025, marking the beginning of a new chapter for Surgimate and ImplantBase. This partnership is a major milestone in Surgimate’s mission to create comprehensive solutions that support the entire surgical process, from coordination to inventory management, and beyond.
About Surgimate
Surgimate is a leading provider of surgical coordination software designed to help surgical practices increase volume, reduce cancellations, and achieve sustainable growth. Headquartered in New York with research and development offices in Israel, Surgimate facilitated over 750,000 surgical events across more than 100 practices in 2024. The company offers innovative tools for surgical project management, reporting, form generation, and more, enabling surgical teams to operate efficiently and deliver exceptional care. With a focus on improving workflow and reducing inefficiencies, Surgimate continues to lead the way in advancing surgical practice management through technology.
Through its investment in ImplantBase, Surgimate is poised to further strengthen its platform and provide even more value to the surgical ecosystem. By combining their expertise in surgical coordination with ImplantBase’s proficiency in inventory management and sales operations, Surgimate is creating a unified platform that enhances collaboration, reduces costs, and improves patient outcomes.
